SC to govt: Why can't SMA med be as cheap in India as in Pakistan, China?
newsare.net
The Supreme Court of India seeks responses from the Centre and Roche on making the spinal muscular atrophy treatment drug Risdiplam affordable in India. The move comes after it was reported that the drug is much cheaper in Pakistan and China due to governmenSC to govt: Why can't SMA med be as cheap in India as in Pakistan, China?
The Supreme Court of India seeks responses from the Centre and Roche on making the spinal muscular atrophy treatment drug Risdiplam affordable in India. The move comes after it was reported that the drug is much cheaper in Pakistan and China due to government interventions.